Formatted for Registrations

GRASP is partnering with the conference on Advancing the Science of Cancer in Latinos and offering our signature Poster Walkthrough in person in San Antonio at the ASCL poster session on February 22. This Poster Walkthrough is being offered exclusively for members of the Latino Patient Advocate Training program (LPAT). LPAT members do not need to register as that being done on the backend.

 

Morning Session – Wed Jun 12, 2024

All times shown are Eastern Time (US/New York)

Group 1A: HR+ Breast Cancer; Hormone & Targeted Therapies; Clinical Trials; Treatment Resistance

Poster #TPS1130: pionERA Breast Cancer (BC): Phase III study of first-line (1L) giredestrant vs. fulvestrant, both combined with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i), in patients (pts) with estrogen receptor-positive (ER+), HER2– locally advanced/metastatic BC (LA/mBC) with resistance to prior adjuvant (adj) endocrine therapy (ET). Oral Abstract #LBA1001: Abemaciclib plus fulvestrant vs fulvestrant alone for HR+, […]
12 Jun
10:00 am - 11:30 am

Group 1B: HER2+ Breast Cancer; Antibody-Drug Conjugates; Targeted Therapies; Clinical Trials; Treatment Resistance

Poster #1105: Tucatinib and trastuzumab for previously treated HER2−mutated metastatic breast cancer (SGNTUC−019): A phase 2 basket study. Poster #TPS1121: Phase 2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 (trastuzumab imbotolimod) +/- pertuzumab (P) in patients (pts) with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab deruxtecan (T-DXd).
12 Jun
10:00 am - 11:30 am

Group 1C: Breast Cancer; Younger Populations

Poster #10580: Evaluating genetic features and clinical characteristics of young women diagnosed with breast cancer by the age of 35. Oral Abstract #10502: Breast cancer polygenic risk score and patient survival outcomes in the Pathways study.
12 Jun
10:00 am - 11:30 am

Group 1D: All Cancers; Symptom Management

Poster #548: Effects of plant-based diet (PBD) and exercise therapy (Ex) on weight and body composition in patients with primary hormone receptor (HR) positive breast cancer: A phase 2 randomized controlled trial. Poster #1079: Prospective, randomized trial on efficacy and safety of cryotherapy and cryocompression therapy as prevention of chemotherapy-induced peripheral neuropathy.
12 Jun
10:00 am - 11:30 am
No event found!

Date

Feb 21 - 23 2024
Expired!

Time

Central Standard Time (CST)
All Day